======= LYPLA2 =======
== Gene Information ==
* **Official Symbol**: LYPLA2
* **Official Name**: lysophospholipase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11313|11313]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O95372|O95372]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LYPLA2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LYPLA2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616143|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Hydrolyzes fatty acids from S-acylated cysteine residues in proteins such as trimeric G alpha proteins, GAP43, ZDHHC6 or HRAS (PubMed:21152083, PubMed:28826475). Deacylates GAP43 (PubMed:21152083). Mediates depalmitoylation of ZDHHC6 (PubMed:28826475). Has lysophospholipase activity (By similarity). {ECO:0000250|UniProtKB:Q9WTL7, ECO:0000269|PubMed:21152083, ECO:0000269|PubMed:28826475}.
|Abhydrolase 5|
|Abhydrolase 6|
|Abhydrolase 2|
|protein depalmitoylation|
|macromolecule depalmitoylation|
|palmitoyl-(protein) hydrolase activity|
|lipoprotein catabolic process|
|carboxylic ester hydrolase activity|
|Golgi stack|
|protein deacylation|
|macromolecule deacylation|
|lipoprotein metabolic process|
|axon guidance|
|neuron projection guidance|
|cadherin binding|
|fatty acid metabolic process|
|axonogenesis|
|axon development|
|cell morphogenesis involved in neuron differentiation|
|neuron projection morphogenesis|
|plasma membrane bounded cell projection morphogenesis|
|cell projection morphogenesis|
|cell part morphogenesis|
|monocarboxylic acid metabolic process|
|chemotaxis|
|taxis|
|cell morphogenesis involved in differentiation|
|neuron projection development|
|protein catabolic process|
|cell morphogenesis|
|neuron development|
|cellular component morphogenesis|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|neuron differentiation|
|organic acid metabolic process|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|lipid metabolic process|
|locomotion|
|generation of neurons|
|movement of cell or subcellular component|
|neurogenesis|
|cell development|
|small molecule metabolic process|
|organic substance catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.7|
|[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|1.74|
|[[:results:exp145|PNU96415E 10μM R03 exp145]]|1.76|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10521
* **Expression level (log2 read counts)**: 4.92
{{:chemogenomics:nalm6 dist.png?nolink |}}